Design of high-specificity binders for peptide–MHC-I complexes
Science · 24.07.2025 · 389 (6758) · 386-391
DOI: 10.1126/science.adv0185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 24.07.2025. Verfasst von Bingxu Liu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class I, Peptides. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Class I major histocompatibility complex (MHC-I) molecules present peptides derived from intracellular antigens on the cell surface for immune surveillance. Proteins that recognize peptide–MHC-I (pMHCI) complexes with specificity for diseased cells could have considerable therapeutic utility. Specificity requires recognition of outward-facing amino acid residues within the disease-associated peptide as well as avoidance of extensive contacts with ubiquitously expressed MHC. We used RFdiffusion to design pMHCI-binding proteins that make extensive contacts with the peptide and identified specific binders for 11 target pMHCs starting from either experimental or predicted pMHCI structures. Upon incorporation into chimeric antigen receptors, designs for eight targets conferred peptide-specific T cell activation. Our approach should have broad utility for both protein- and cell-based pMHCI targeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Washington, Seattle, WA, USA.
- Institute for Protein Design, University of Washington, Seattle, WA, USA.
- Bioengineering Graduate Program, University of Washington, Seattle, WA, USA.
- Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
ORCID-Profile: Bingxu Liu, Nathan F Greenwood, Julia E Bonzanini, Jeremy Meyerberg, Tao Dao, Xinyu Xiang, Russell Ault, Jazmin Sharp, Chunyu Wang, Dionne K Vafeados, Nicole Roullier, Armita Nourmohammad, David A Scheinberg, K Christopher Garcia, David Baker
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- Howard Hughes Medical Institute
- NIGMS NIH HHS
Zitieren
APA
Liu, B., Greenwood, N. F., Bonzanini, J. E., Motmaen, A., Meyerberg, J., Dao, T., Xiang, X., Ault, R., Sharp, J., Wang, C., Visani, G. M., Vafeados, D. K., Roullier, N., Nourmohammad, A., Scheinberg, D. A., Garcia, K. C., & Baker, D. (2025). Design of high-specificity binders for peptide–MHC-I complexes. Science, 389(6758), 386-391. https://doi.org/10.1126/science.adv0185
Vancouver
Liu B, Greenwood NF, Bonzanini JE, Motmaen A, Meyerberg J, Dao T, et al. Design of high-specificity binders for peptide–MHC-I complexes. Science. 2025;389(6758):386-391. doi:10.1126/science.adv0185
BibTeX
@article{Liu2025,
author = {Liu, Bingxu and Greenwood, Nathan F and Bonzanini, Julia E and Motmaen, Amir and Meyerberg, Jeremy and Dao, Tao and Xiang, Xinyu and Ault, Russell and Sharp, Jazmin and Wang, Chunyu and Visani, Gian Marco and Vafeados, Dionne K and Roullier, Nicole and Nourmohammad, Armita and Scheinberg, David A and Garcia, K Christopher and Baker, David},
title = {Design of high-specificity binders for peptide–MHC-I complexes},
journal = {Science},
year = {2025},
volume = {389},
number = {6758},
pages = {386--391},
doi = {10.1126/science.adv0185}
}
EUVIMED